Cargando…
Blood–Brain Barrier Impairment in Patients Living with HIV: Predictors and Associated Biomarkers
Despite the substantial changes resulting from the introduction of combination antiretroviral therapy (cART), the prevalence of HIV-associated neurocognitive disorders (HAND) remains substantial. Blood–brain barrier impairment (BBBi) is a frequent feature in people living with HIV (PLWH) and it may...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151579/ https://www.ncbi.nlm.nih.gov/pubmed/34065785 http://dx.doi.org/10.3390/diagnostics11050867 |
_version_ | 1783698416531931136 |
---|---|
author | Caligaris, Giulia Trunfio, Mattia Ghisetti, Valeria Cusato, Jessica Nigra, Marco Atzori, Cristiana Imperiale, Daniele Bonora, Stefano Di Perri, Giovanni Calcagno, Andrea |
author_facet | Caligaris, Giulia Trunfio, Mattia Ghisetti, Valeria Cusato, Jessica Nigra, Marco Atzori, Cristiana Imperiale, Daniele Bonora, Stefano Di Perri, Giovanni Calcagno, Andrea |
author_sort | Caligaris, Giulia |
collection | PubMed |
description | Despite the substantial changes resulting from the introduction of combination antiretroviral therapy (cART), the prevalence of HIV-associated neurocognitive disorders (HAND) remains substantial. Blood–brain barrier impairment (BBBi) is a frequent feature in people living with HIV (PLWH) and it may persist despite effective antiretroviral treatment. A cross-sectional study was performed in PLWH who underwent lumbar puncture for clinical reasons or research protocols and several cerebrospinal fluid biomarkers were studied. BBBi was defined as cerebrospinal fluid-to-serum albumin ratio (CSAR) >6.5 (<40 years) or >8 (>40 years). We included 464 participants: 147 cART-naïve and 317 on cART. Male sex was prevalent in both groups (72.1% and 72.2% respectively); median age was 44 (38–52) years in naïve and 49 (43–57) years in treated subjects. BBBi was observed in 35.4% naïve and in 22.7% treated participants; the use of integrase inhibitors was associated with a lower prevalence (18.3 vs. 30.9%, p = 0.050). At multivariate binary logistic regression (including age and sex) nadir CD4 cell count (p = 0.034), presence of central nervous system (CNS) opportunistic infections (p = 0.024) and cerebrospinal fluid (CSF) HIV RNA (p = 0.002) in naïve participants and male sex (p = 0.021), a history of CNS opportunistic infections (p = 0.001) and CSF HIV RNA (p = 0.034) in treated patients were independently associated with BBBi. CSF cells and neopterin were significantly higher in participants with BBBi. BBBi was prevalent in naïve and treated PLWH and it was associated with CSF HIV RNA and neopterin. Systemic control of viral replication seems to be essential for BBB integrity while sex and treatment influence need further studies. |
format | Online Article Text |
id | pubmed-8151579 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81515792021-05-27 Blood–Brain Barrier Impairment in Patients Living with HIV: Predictors and Associated Biomarkers Caligaris, Giulia Trunfio, Mattia Ghisetti, Valeria Cusato, Jessica Nigra, Marco Atzori, Cristiana Imperiale, Daniele Bonora, Stefano Di Perri, Giovanni Calcagno, Andrea Diagnostics (Basel) Article Despite the substantial changes resulting from the introduction of combination antiretroviral therapy (cART), the prevalence of HIV-associated neurocognitive disorders (HAND) remains substantial. Blood–brain barrier impairment (BBBi) is a frequent feature in people living with HIV (PLWH) and it may persist despite effective antiretroviral treatment. A cross-sectional study was performed in PLWH who underwent lumbar puncture for clinical reasons or research protocols and several cerebrospinal fluid biomarkers were studied. BBBi was defined as cerebrospinal fluid-to-serum albumin ratio (CSAR) >6.5 (<40 years) or >8 (>40 years). We included 464 participants: 147 cART-naïve and 317 on cART. Male sex was prevalent in both groups (72.1% and 72.2% respectively); median age was 44 (38–52) years in naïve and 49 (43–57) years in treated subjects. BBBi was observed in 35.4% naïve and in 22.7% treated participants; the use of integrase inhibitors was associated with a lower prevalence (18.3 vs. 30.9%, p = 0.050). At multivariate binary logistic regression (including age and sex) nadir CD4 cell count (p = 0.034), presence of central nervous system (CNS) opportunistic infections (p = 0.024) and cerebrospinal fluid (CSF) HIV RNA (p = 0.002) in naïve participants and male sex (p = 0.021), a history of CNS opportunistic infections (p = 0.001) and CSF HIV RNA (p = 0.034) in treated patients were independently associated with BBBi. CSF cells and neopterin were significantly higher in participants with BBBi. BBBi was prevalent in naïve and treated PLWH and it was associated with CSF HIV RNA and neopterin. Systemic control of viral replication seems to be essential for BBB integrity while sex and treatment influence need further studies. MDPI 2021-05-12 /pmc/articles/PMC8151579/ /pubmed/34065785 http://dx.doi.org/10.3390/diagnostics11050867 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Caligaris, Giulia Trunfio, Mattia Ghisetti, Valeria Cusato, Jessica Nigra, Marco Atzori, Cristiana Imperiale, Daniele Bonora, Stefano Di Perri, Giovanni Calcagno, Andrea Blood–Brain Barrier Impairment in Patients Living with HIV: Predictors and Associated Biomarkers |
title | Blood–Brain Barrier Impairment in Patients Living with HIV: Predictors and Associated Biomarkers |
title_full | Blood–Brain Barrier Impairment in Patients Living with HIV: Predictors and Associated Biomarkers |
title_fullStr | Blood–Brain Barrier Impairment in Patients Living with HIV: Predictors and Associated Biomarkers |
title_full_unstemmed | Blood–Brain Barrier Impairment in Patients Living with HIV: Predictors and Associated Biomarkers |
title_short | Blood–Brain Barrier Impairment in Patients Living with HIV: Predictors and Associated Biomarkers |
title_sort | blood–brain barrier impairment in patients living with hiv: predictors and associated biomarkers |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151579/ https://www.ncbi.nlm.nih.gov/pubmed/34065785 http://dx.doi.org/10.3390/diagnostics11050867 |
work_keys_str_mv | AT caligarisgiulia bloodbrainbarrierimpairmentinpatientslivingwithhivpredictorsandassociatedbiomarkers AT trunfiomattia bloodbrainbarrierimpairmentinpatientslivingwithhivpredictorsandassociatedbiomarkers AT ghisettivaleria bloodbrainbarrierimpairmentinpatientslivingwithhivpredictorsandassociatedbiomarkers AT cusatojessica bloodbrainbarrierimpairmentinpatientslivingwithhivpredictorsandassociatedbiomarkers AT nigramarco bloodbrainbarrierimpairmentinpatientslivingwithhivpredictorsandassociatedbiomarkers AT atzoricristiana bloodbrainbarrierimpairmentinpatientslivingwithhivpredictorsandassociatedbiomarkers AT imperialedaniele bloodbrainbarrierimpairmentinpatientslivingwithhivpredictorsandassociatedbiomarkers AT bonorastefano bloodbrainbarrierimpairmentinpatientslivingwithhivpredictorsandassociatedbiomarkers AT diperrigiovanni bloodbrainbarrierimpairmentinpatientslivingwithhivpredictorsandassociatedbiomarkers AT calcagnoandrea bloodbrainbarrierimpairmentinpatientslivingwithhivpredictorsandassociatedbiomarkers |